Form 4: Roivant Sciences CEO Matthew Gline Reports Share Disposal for Tax Obligations
SEC Form 4 Filing
Roivant Sciences CEO Matthew Gline disposed of 10,945 common shares to cover tax obligations related to vested RSUs.
Summary
- On February 20, 2025, Matthew Gline, CEO of Roivant Sciences Ltd., disposed of 10,945 common shares.
- The transaction was executed to cover tax withholding obligations related to the vesting and settlement of previously granted Restricted Stock Units (RSUs).
- The shares were disposed of at a price of $10.72 per share.
- Following the transaction, Gline directly owns 17,316,601 common shares.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to tax obligations, and does not contain any information that would significantly impact investor sentiment.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a standard procedure for covering tax obligations.
Key Dates
| Date | Description |
|---|---|
| 02/20/2025 | Date of transaction: Matthew Gline disposed of shares to cover tax obligations. |
| 02/24/2025 | Date of signature on the Form 4 filing. |
Keywords
Roivant Sciences, Matthew Gline, Form 4, Share Disposal, RSUs, Tax Obligations, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.